|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Roshan MH, Tambo A and Pace NP: The role
of testosterone in colorectal carcinoma: Pathomechanisms and open
questions. EPMA J. 7:222016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Calon A, Espinet E, Palomo-Ponce S,
Tauriello DV, Iglesias M, Céspedes MV, Sevillano M, Nadal C, Jung
P, Zhang XH, et al: Dependency of colorectal cancer on a
TGF-beta-driven program in stromal cells for metastasis initiation.
Cancer Cell. 22:571–584. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sakuma K, Sasaki E, Kimura K, Komori K,
Shimizu Y, Yatabe Y and Aoki M: HNRNPLL, a newly identified
colorectal cancer metastasis suppressor, modulates alternative
splicing of CD44 during epithelial-mesenchymal transition. Gut.
67:1103–1111. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yan G, Zhao H, Zhang Q, Zhou Y, Wu L, Lei
J, Wang X, Zhang J, Zhang X, Zheng L, et al: A
RIPK3-PGE2 circuit mediates myeloid-derived suppressor
cell-potentiated colorectal carcinogenesis. Cancer Res.
78:5586–5599. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Geerts D, Schilderink N, Jorritsma G and
Versteeg R: The role of the MEIS homeobox genes in neuroblastoma.
Cancer Lett. 197:87–92. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Salzberg A, Elias S, Nachaliel N, Bonstein
L, Henig C and Frank D: A Meis family protein caudalizes neural
cell fates in Xenopus. Mech Dev. 80:3–13. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bhanvadia RR, VanOpstall C, Brechka H,
Barashi NS, Gillard M, McAuley EM, Vasquez JM, Paner G, Chan WC,
Andrade J, et al: MEIS1 and MEIS2 expression and prostate cancer
progression: A role for HOXB13 binding partners in metastatic
disease. Clin Cancer Res. 24:3668–3680. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jeong JH, Park SJ, Dickinson SI and Luo
JL: A constitutive intrinsic inflammatory signaling circuit
composed of miR-196b, Meis2, PPP3CC, and p65 drives prostate cancer
castration resistance. Mol Cell. 65:154–167. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zha Y, Xia Y, Ding J, Choi JH, Yang L,
Dong Z, Yan C, Huang S and Ding HF: MEIS2 is essential for
neuroblastoma cell survival and proliferation by transcriptional
control of M-phase progression. Cell Death Dis. 5:e14172014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Vegi NM, Klappacher J, Oswald F, Mulaw MA,
Mandoli A, Thiel VN, Bamezai S, Feder K, Martens JHA, Rawat VPS, et
al: MEIS2 is an oncogenic partner in AML1-ETO-positive AML. Cell
Rep. 16:498–507. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Crijns AP, de Graeff P, Geerts D, Ten Hoor
KA, Hollema H, van der Sluis T, Hofstra RM, de Bock GH, de Jong S,
van der Zee AG, et al: MEIS and PBX homeobox proteins in ovarian
cancer. Eur J Cancer. 43:2495–2505. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Smith JJ, Deane NG, Wu F, Merchant NB,
Zhang B, Jiang A, Lu P, Johnson JC, Schmidt C, Bailey CE, et al:
Experimentally derived metastasis gene expression profile predicts
recurrence and death in patients with colon cancer.
Gastroenterology. 138:958–968. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sheffer M, Bacolod MD, Zuk O, Giardina SF,
Pincas H, Barany F, Paty PB, Gerald WL, Notterman DA and Domany E:
Association of survival and disease progression with chromosomal
instability: A genomic exploration of colorectal cancer. Proc Natl
Acad Sci USA. 106:7131–7136. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Qi J, Yu Y, Akilli Ozturk O, Holland JD,
Besser D, Fritzmann J, Wulf-Goldenberg A, Eckert K, Fichtner I and
Birchmeier W: New wnt/beta-catenin target genes promote
experimental metastasis and migration of colorectal cancer cells
through different signals. Gut. 65:1690–1701. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang Z, Yang J, Di J, Cui M, Xing J, Wu F,
Wu W, Yang H, Zhang C, Yao Z, et al: Downregulated USP3 mRNA
functions as a competitive endogenous RNA of SMAD4 by sponging
miR-224 and promotes metastasis in colorectal cancer. Sci Rep.
7:42812017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang L, Liu Y, Wang M, Qian Y, Dai X, Zhu
Y, Chen J, Guo S and Hisamitsu T: Celastrus orbiculatus extract
triggers apoptosis and autophagy via PI3K/Akt/mTOR inhibition in
human colorectal cancer cells. Oncol Lett. 12:3771–3778. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Qian DC, Xiao X, Byun J, Suriawinata, Her
SC, Amos CI and Barth RJ Jr: PI3K/Akt/mTOR signaling and plasma
membrane proteins are implicated in responsiveness to adjuvant
dendritic cell vaccination for metastatic colorectal cancer. Clin
Cancer Res. 23:399–406. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xu L, Zhang Y, Wang H, Zhang G, Ding Y and
Zhao L: Tumor suppressor miR-1 restrains epithelial-mesenchymal
transition and metastasis of colorectal carcinoma via the MAPK and
PI3K/AKT pathway. J Transl Med. 12:2442014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pandurangan AK: Potential targets for
prevention of colorectal cancer: A focus on PI3K/Akt/mTOR and Wnt
pathways. Asian Pac J Cancer Prev. 14:2201–2205. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fricke F, Lee J, Michalak M, Warnken U,
Hausser I, Suarez- Carmona M, Halama N, Schnölzer M, Kopitz J and
Gebert J: TGFBR2-dependent alterations of exosomal cargo and
functions in DNA mismatch repair-deficient HCT116 colorectal cancer
cells. Cell Commun Signal. 15:142017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lee J, Katzenmaier EM, Kopitz J and Gebert
J: Reconstitution of TGFBR2 in HCT116 colorectal cancer cells
causes increased LFNG expression and enhanced
N-acetyl-D-glucosamine incorporation into Notch1. Cell Signal.
28:1105–1113. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ding J, Li J, Wang H, Tian Y, Xie M, He X,
Ji H, Ma Z, Hui B, Wang K and Ji G: Long noncoding RNA CRNDE
promotes colorectal cancer cell proliferation via epigenetically
silencing DUSP5/CDKN1A expression. Cell Death Dis. 8:e29972017.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dunlop MG, Dobbins SE, Farrington SM,
Jones AM, Palles C, Whiffin N, Tenesa A, Spain S, Broderick P, Ooi
LY, et al: Common variation near CDKN1A, POLD3 and SHROOM2
influences colorectal cancer risk. Nat Genet. 44:770–776. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu Y, Chen X, Cheng R, Yang F, Yu M, Wang
C, Cui S, Hong Y, Liang H, Liu M, et al: The Jun/miR-22/HuR
regulatory axis contributes to tumourigenesis in colorectal cancer.
Mol Cancer. 17:112018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bae JA, Yoon S, Park SY, Lee JH, Hwang JE,
Kim H, Seo YW, Cha YJ, Hong SP, Kim H, et al: An unconventional
KITENIN/ErbB4-mediated downstream signal of EGF upregulates c-jun
and the invasiveness of colorectal cancer cells. Clin Cancer Res.
20:4115–4128. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Takeda K, Kinoshita I, Shimizu Y, Ohba Y,
Itoh T, Matsuno Y, Shichinohe T and Dosaka-Akita H:
Clinicopathological significance of expression of p-c-Jun, TCF4 and
beta-Catenin in colorectal tumors. BMC Cancer. 8:3282008.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Peng J, Ou Q, Pan Z, Zhang R, Zhao Y, Deng
Y, Lu Z, Zhang L, Li C, Zhou Y, et al: Serum CNPY2 isoform 2
represents a novel biomarker for early detection of colorectal
cancer. Aging. 10:1921–1931. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cui BH and Hong X: miR-6852 serves as a
prognostic biomarker in colorectal cancer and inhibits tumor growth
and metastasis by targeting TCF7. Exp Ther Med. 16:879–885.
2018.PubMed/NCBI
|
